Alexander Drilon named chief of the Early Drug Development Service at MSK

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Alexander Drilon was named chief of the Early Drug Development Service in the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Login